With menopause comes the onset of hot flashes. These are the result of the drop in estrogen in the blood. Replacing estrogen is the most effective way of eliminating hot flashes but because of the health risks, taking estrogen replacement is an unacceptable option for many women. A recent study in the Journal of Clinical Oncology reports on the use of other prescription drugs that can alleviate hot flashes. Watch my video on the subject for a more in depth discussion.
Tag Archives: hot flashes
Is Post-Menopausal Estrogen Therapy (HRT) Ready for a Come Back? Part 1
blood clot, breast cancer, cancer risks, gary pepper, health initiative, heart attack, heart attack risk, heart disease, heart health, hormone replacement therapy, hot flashes, HRT, hrt increases, losing estrogen, miseries, onset of menopause, post menopausal symptoms, progesterone, reassessment, risk of heart attack, time scientists 
Comment
Once a common solution for the Miseries of Menopause, hormone replacement therapy (HRT) with estrogen was abandoned almost overnight in 2002 with the publication of the Women’s Health Initiative (WHI) results. The WHI did not dispute the fact that HRT is the best method of reversing post-menopausal symptoms such as hot flashes and insomnia but it did overturn some cherished beliefs as far as women’s heart health is concerned.
Women have a much lower risk of heart attack then men until they reach menopause. At menopause when the ovaries stop making estrogen the risk of heart attack climbs rapidly until it equals that of men. Common sense suggests that if losing estrogen causes increased heart attack risk then replacing the estrogen should prevent this. What the WHI appears to show is that HRT does not protect women from heart disease, but may actually increase the risk above the normal post-menopausal risk. Worse yet is the WHI conclusion that HRT increases the risk of breast cancer and of blood clot complications (thromboembolic disease). It is no wonder that in 2002 HRT took its place with smoking as the scourge of womens’ health.
Since that time scientists have reevaluated the WHI data and more work on HRT risk versus benefit has been done. What is evolving from this reassessment is that the use of progesterone in the WHI participants and the time from onset of menopause until the time HRT was started, both play important roles in how often women developed heart disease or cancer. Additionally, a new class of drugs when use together with HRT may block the cancer risks associated with HRT. In Part 2 of this article I will be covering these aspects. Stay tuned!
Gary Pepper, M.D.
Editor-in- Chief, metabolism.com